George Newman, MD
Internal Medicine · Knoxville, TNNPI 1083616957
Payments from drug & device makers
Across 296 payments — averaging $2304.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$269K
- Bayer$195K
- Merck$49K
- Boehringer Ingelheim$44K
- Vertex$33K
- Novartis$32K
- plus $60K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 105 | $268,684 |
| Bayer | 51 | $195,106 |
| Merck | 3 | $48,713 |
| Boehringer Ingelheim | 6 | $44,434 |
| Vertex | 1 | $32,836 |
| Novartis | 6 | $32,328 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $14,193 |
| Ardelyx, Inc. | 9 | $10,853 |
| Alnylam Pharmaceuticals Inc. | 2 | $8,750 |
| AbbVie | 1 | $8,570 |
| Novo Nordisk AS | 1 | $6,086 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 44 | $5,059 |
| Janssen Research & Development, LLC | 1 | $4,334 |
| AstraZeneca(2 entities) | 12 | $645 |
| Biogen | 1 | $606 |
| Amgen(2 entities) | 13 | $217 |
| GSK | 8 | $149 |
| Nxstage Medical, Inc. | 1 | $129 |
| Otsuka America Pharmaceutical, Inc. | 1 | $96 |
| Akebia Therapeutics Inc | 5 | $76 |
| Vifor Pharma, Inc. | 4 | $66 |
| OPKO Pharmaceuticals, LLC | 4 | $52 |
| Daiichi Sankyo Inc. | 3 | $50 |
| Travere Therapeutics, Inc. | 3 | $49 |
| Mallinckrodt Hospital Products Inc. | 3 | $45 |
| Aurinia Pharma U.S., Inc. | 2 | $39 |
| Medtronic | 1 | $21 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Boehringer Ingelheim International GmbH | 1 | $13 |
How this compares
$682,254 in reported general payments places this provider in the 95th percentile of 2,216 internal medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Knoxville
- Amanda Moore MillerKnoxville$2.3M
- Dennis DeruelleKnoxville$263K
- Lewis HagoodKnoxville$143K
- Johnny AltawilKnoxville$23K
- Mark McKenzieChattanooga$11.9M
- Bernard GrunstraBristol$6.4M
- Jewel WhiteKingsport$5.7M
- Judith WhiteKingsport$5.6M
- Obadias MarquezOoltewah$2.8M
- Rick WhilesBristol$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.